Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 157.0
(1.29%)
TWD 157.0
(1.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -226.67 Million TWD | 53.02% |
| 2022 | -482.13 Million TWD | -475.76% |
| 2021 | 128.3 Million TWD | 144.74% |
| 2020 | -286.78 Million TWD | -159.23% |
| 2019 | -186.64 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -115.3 Million TWD | -1.89% |
| 2024 Q2 | -70.99 Million TWD | 158.73% |
| 2023 Q2 | -145.31 Million TWD | -197.2% |
| 2023 Q4 | -113.31 Million TWD | 3.47% |
| 2023 FY | - TWD | 53.02% |
| 2023 Q1 | 149.49 Million TWD | 364.12% |
| 2023 Q3 | -117.39 Million TWD | 19.21% |
| 2022 Q3 | -77.93 Million TWD | 0.0% |
| 2022 FY | - TWD | -475.76% |
| 2022 Q4 | -56.6 Million TWD | 27.38% |
| 2021 FY | - TWD | 144.74% |
| 2020 FY | - TWD | -159.23% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 157.59% |
| Level Biotechnology Inc. | 98.7 Million TWD | 329.654% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 152.283% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -406.668% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -214.329% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -798.339% |
| GlycoNex Incorporation | -126.82 Million TWD | -78.73% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -57.749% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 1139.331% |
| Visgeneer Inc. | 973 Thousand TWD | 23396.814% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -183.093% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 33.228% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 124.206% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 327.048% |
| Neith Corporation | -33.61 Million TWD | -574.436% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 77.128% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -12949.971% |
| Enimmune corporation | -228.96 Million TWD | 0.998% |
| TaiRx, Inc. | -208.64 Million TWD | -8.642% |
| CHO Pharma, Inc. | -277.73 Million TWD | 18.382% |
| EirGenix Inc. | -664.4 Million TWD | 65.883% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 406.72% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 427.839% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 78.843% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -100.412% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 750.663% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -263.61% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -761.894% |
| BiOptic Inc. | 65.03 Million TWD | 448.532% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 66.785% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -586.778% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -312.78% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -1178.788% |
| VBI | -6.97 Million TWD | -3151.262% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -118.769% |
| RBC Bioscience Corporation | 36.54 Million TWD | 720.237% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -390.178% |
| NaviFUS Corp. | -55.79 Million TWD | -306.269% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -1265.695% |
| Sinew Pharma Inc. | -163.63 Million TWD | -38.53% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -268.582% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 217.815% |
| AP Biosciences Inc | -325.51 Million TWD | 30.363% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 78.3% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -532.366% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 878.16% |
| Intech Biopharm Corporation | -219.58 Million TWD | -3.23% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 66.38% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -404.278% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -40.919% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 134.58% |
| TCI GENE Inc. | 25.98 Million TWD | 972.476% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -104.883% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 20.123% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -55.291% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 1736.664% |
| PharmaEngine, Inc. | 347.3 Million TWD | 165.268% |
| Savior Lifetec Corporation | 219.6 Million TWD | 203.221% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 231.614% |
| OBI Pharma, Inc. | -855.08 Million TWD | 73.491% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -144.891% |
| Acepodia, Inc. | -764.51 Million TWD | 70.35% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 50.732% |